NFKB1 and hepatocellular carcinoma: When comparing HCC-induced rats to those given CR, SB, or both, the level of NF-κB-p65 was dramatically lowered in all the treatments, and the upregulation of NF-κB-p65 levels was additively decreased by the CR–SB combination.